US 11459360
Recombinant HIV-1 envelope proteins and their use
granted A61KA61K2039/55555A61K2039/55561
Quick answer
US patent 11459360 (Recombinant HIV-1 envelope proteins and their use) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Sep 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Oct 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61K, A61K2039/55555, A61K2039/55561, A61K2039/55577, A61K39/12